111¦~¤G¤ë¸¹ ¹D ªk ªk °T (358) |
DEEP & FAR |
|
¬O§_¦³°Ê¾÷¥Í²£¥Î©ó°ª¤À¤l§÷®Æªº¤£¦P´¹Åé¦h§ÎÅé Osaka Gas Chemicals Co., Ltd. v. Taoka Chemical Co., Ltd.¡A®×¥ó½s¸¹2017 ¡]Gyo-Ke¡^10236&10237¡]2019¦~2¤ë14¤é§@¥Xªº§P¨M¡^ |
¶À§ÀR ±M§Q¤uµ{®v ¡E¶§©ú¤j¾Çª«²zªvÀø¨t ¡E¶§©ú¤j¾Ç¥Íª«ÃÄ¾Ç©Ò |
|
|
||
±M§QÅv¤HTaoka Chemical©ó2008¦~Àò±o¤F¤@¶µ»P9,9-Âù(4-(2-ßm°ò¤A®ñ°ò)f°ò)¬t(9,9-bis(4-(2-hydroxyethoxy)phenyl)fluorine, BHPF)ªº´¹Åé¦h§ÎÅ骺¬yµ{¦³Ãöªº±M§Q¡C°w¹ïTaokaªº±M§Q¡AOsaka Gas Chemicals (OGC)©ó2013¦~¦V¤é¥»¯S³\ÆU(JPO)´£¥XµL®Ä¼f§P(invalidation trial)¡CJPO©ó2014¦~§@¥XºM¾POGC¤§½Ð¨Dªº¨M©w (JPOªº²Ä¤@¦¸¨M©w)¡COGC©ó2014¦~°w¹ïJPOªº²Ä¤@¦¸¨M©w¦VIPHC´£°_¤W¶D¡CIPHC©ó2016 ¦~§@¥XºM¾PJPOªº²Ä¤@¦¸¨M©wªº§P¨M(IPHCªº¥ý«e§P¨M)¡CTaoka©ó2017¦~°w¹ïIPHCªº¥ý«e§P¨M¦V³Ì°ªªk°|´£°_¤W¶D¡A¦ý¤W¶D¥¼³Q±µ¨ü¡A¦]¦¹IPHCªº¥ý«e§P¨M¬O³Ì²×§P¨M¥B¨ã¦³¬ù§ô¤O¡C
¦]¦¹¡A¸Ó®×³Qµo¦^JPO¡A¥B¡ATaoka ©ó2017¦~n¨D§ó¥¿½Ð¨D¶µ¡A¥]¬A¨ú®ø½Ð¨D¶µ5¤Î10¡CJPO©Ó»{¸Ó§ó¥¿¡A¨Ã©ó2017¦~§@¥X½Ð¨D¶µ7µL®Ä¡B»é¦^¹ï½Ð¨D¶µ1¦Ü4¡B6¡B8¤Î9ªºn¨D¡B¨Ã»é¦^¤F¹ï½Ð¨D¶µ5¤Î10ªºn¨Dªº¨M©w¡]JPOªº²Ä¤G¦¸¨M©w¡^¡COGC¤ÎTaoka©ó2017¦~¤À§O°w¹ïJPO¹ï½Ð¨D¶µ1¦Ü4¡B6¡B8¤Î9ªº²Ä¤G¦¸¨M©w¡B¥H¤Î°w¹ïJPO¹ï½Ð¨D¶µ7ªº²Ä¤G¦¸¨M©w¦VIPHC ´£°_¤W¶D¡C
Taokaªº¨tª§±M§Qªº§ó¥¿«á½Ð¨D¶µ1¦p¤U¡G
¤@ºØ²£¥Í9,9-Âù(4-(2-ßm°ò¤A®ñ°ò)f°ò)¬t(9,9-bis(4-(2-hydroxyethoxy)phenyl)fluorine, BHPF)ªº¤@´¹Åé¦h§ÎÅ骺¤èªk¡A¥]¬A¥H¤U¨BÆJ¡G
¦b¤@Âø¦h»Ä(heteropolyacid)ªº¦s¦b¤U¡A±NÐpà¬(fluorenone)»P2-f®ñ¤A¾J(2-phenoxyethanol)¶i¦æ¤ÏÀ³¡FµM«á
±q©ÒÀò±oªº¤ÏÀ³²V¦Xª«¦b§C©ó50¢J¤U°_©lBHPFªº¨I¿n§@¥Î¥HÀò±oBHPFªº¤@²Ê²£ª«¡F±µµÛ
¦b¤@ªÚ»ÖL·»¾¯¤¤·»¸Ñ¨ã¦³85%©Î§ó°ª¯Â«×ªº¸Ó²Ê²£ª«¡FµM«á
¦b65¢J©Î§ó°ª·Å«×¤U°_©lBHPFªº¨I¿n§@¥Î¡C